Febrile infection-related epilepsy syndrome
| Febrile infection-related epilepsy syndrome | |
|---|---|
| Synonyms | FIRES |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Seizures, fever, encephalopathy |
| Complications | Status epilepticus, cognitive impairment, neurological deficits |
| Onset | Typically in children and adolescents |
| Duration | Chronic |
| Types | N/A |
| Causes | Unknown, often follows a febrile illness |
| Risks | Genetic predisposition, autoimmune disorders |
| Diagnosis | Clinical diagnosis, EEG, MRI |
| Differential diagnosis | Infectious encephalitis, autoimmune encephalitis, Dravet syndrome |
| Prevention | N/A |
| Treatment | Antiepileptic drugs, immunotherapy, ketogenic diet, anesthetic agents |
| Medication | N/A |
| Prognosis | Variable, often poor with significant morbidity |
| Frequency | Rare |
| Deaths | N/A |
Alternate names
FIRES; Acute encephalitis with refractory repetitive partial seizures; AERRPS; Acute non-herpetic encephalitis with severe refractory status epilepticus; Devastating epileptic encephalopathy in school-aged children; DESC syndrome; Fever-induced refractory epileptic encephalopathy in school-aged children; Idiopathic catastrophic epileptic encephalopathy; Severe refractory status epilepticus owing to presumed encephalitis; Status epilepticus owing to presumed encephalitis; Febrile infection-related epilepsy syndrome
Summary
FIRES (Febrile Infection-Related Epilepsy Syndrome) is a sub-type of cryptogenic new-onset refractory status epilepticus (NORSE). NORSE describes a condition in which a healthy person who has not had seizures before, begins having seizures. Of note, FIRES previously was considered a separate condition that occurred only in children, while NORSE was described only in adults. However, there is now consensus that FIRES and NORSE without a prior fever can both be described in people of any age.
Cause
Some researchers believe cryptogenic NORSE, including FIRES, may be an inflammatory disorder. Others suggest that an unidentified brain infection may cause some cases.
Inheritance
Currently there is no evidence that NORSE runs in families (hereditary); however, studies indicate that changes in certain genes, including the SCN2A and IL1RN gene(s) may increase the risk to develop NORSE.
Signs and symptoms
- FIRES starts with a febrile illness up to two weeks before seizure onset.
- These seizures damage the frontal lobe's cognitive brain function such as memory and sensory abilities.
- This can result in learning disabilities, behavioral disorders, memory issues, sensory changes, and possibly death.
- Children continue to have seizures throughout their lives.
Diagnosis
- FIRES is difficult to diagnose due to its rarity and lack of definitive biomarker.
- It is often diagnosed by ruling out other options such as infectious, toxic, metabolic, and genetic causes.
- FIRES will consist of two phases - acute and chronic.
- The acute phase consists of highly recurrent focal seizures, rapidly evolving into refractory status epilepticus.
- The chronic phase consists of drug-resistant epilepsy with cognitive impairment.
Treatment
Treatment for NORSE (including FIRES) requires being cared for in an intensive care unit, at least until status epilepticus (SE) subsides and consciousness is regained. If an underlying cause of new-onset refractory status epilepticus (NORSE) is identified, treatment will include addressing the cause. There is no standard treatment for cryptogenic NORSE (when the cause cannot be found).
NIH genetic and rare disease info
Febrile infection-related epilepsy syndrome is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - Febrile infection-related epilepsy syndrome
|
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Deepika vegiraju, Prab R. Tumpati, MD